Biogen Inc. (BIIB) financial statements (2020 and earlier)

Company profile

Business Address 225 BINNEY STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,9141,2253,6894,8953,4291,8451,223
Cash and cash equivalents2,9141,2251,5742,3271,3081,205603
Short-term investments  2,1152,5692,121640620
Receivables1,8811,9591,7871,4421,2271,292824
Inventory, net of allowances, customer advances and progress billings8049309031,002893804659
Inventory8049309031,002893804659
Prepaid expense 271     
Other current assets6316889621,093837447226
Other undisclosed current assets2,1522,569533301315283253
Total current assets:8,3827,6417,8738,7326,7004,6733,185
Noncurrent Assets
Inventory, Noncurrent 7     
Operating lease, right-of-use asset427
Property, plant and equipment3,2473,6013,1822,5022,1881,7661,751
Long-term investments and receivables  3,0572,8292,7601,471626
Long-term investments  3,0572,8292,7601,471626
Intangible assets, net (including goodwill)9,2858,8268,5127,4786,7495,7895,708
Goodwill5,7585,7064,6333,6692,6641,7601,233
Intangible assets, net (excluding goodwill)3,5273,1203,8803,8084,0854,0294,475
Other noncurrent assets1,2531,6911,0281,3361,108619594
Deferred tax assets, net2,154     
Other undisclosed noncurrent assets4,6401,369     
Total noncurrent assets:18,85317,64815,77914,14512,8059,6448,678
TOTAL ASSETS:27,23425,28923,65322,87719,50514,31711,863
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6024344645124761,420743
Accounts payable531371396280267229220
Accrued liabilities     629 
Employee-related liabilities     394343
Taxes payable716468232209168180
Debt1,496 35533
Liability for uncertainty in income taxes     8099
Business combination, contingent consideration, liability     266
Deferred revenue and credits   121173
Other liabilities2,7662,8612,9012,9042,0971,8191,355
Other undisclosed current liabilities     (1,490)(616)
Total current liabilities:4,8643,2953,3683,4202,5782,2201,758
Noncurrent Liabilities
Long-term debt and lease obligation, including:6,413  1618563568
Long-term debt, excluding current maturities6,000  6,5566,560563568
Operating lease, liability413
Other undisclosed long-term debt and lease obligation   (6,540)(6,542)  
Liabilities, other than long-term debt2,1523,0261,7518161,0311,150892
Accounts payable and accrued liabilities803    249 
Deferred tax liabilities, net1,6361239312551233
Other liabilities1,3491,3891,629723906650659
Business combination, contingent consideration, liability     200
Other undisclosed noncurrent liabilities4675,9375,9356,4966,503(430)25
Total noncurrent liabilities:9,0318,9627,6867,3287,5521,2831,484
Total liabilities:13,89512,25711,05510,74810,1303,5033,242
Stockholders' equity
Stockholders' equity attributable to parent13,34313,04012,61312,1409,37310,8098,620
Common stock0000000
Treasury stock, value(2,977)(2,977)(2,977)(2,612)(2,612)(2,612)(1,725)
Additional paid in capital  98  4,1964,024
Accumulated other comprehensive loss(135)(240)(318)(320)(224)(59)(28)
Retained earnings16,45516,25715,81015,07212,2089,2846,349
Stockholders' equity attributable to noncontrolling interest(4)(8)(15)(12)251
Total stockholders' equity:13,33913,03212,59812,1299,37510,8148,621
TOTAL LIABILITIES AND EQUITY:27,23425,28923,65322,87719,50514,31711,863

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues14,37813,45312,27411,44910,7649,7036,932
Revenue, net10,71510,1349,4258,5085,806
Cost of revenue(2,623)(2,736)(1,805)(1,527)(1,282)(1,222)(943)
Cost of goods and services sold(1,955)(1,816)(1,707)(1,527)(1,282)(1,222)(905)
Other undisclosed gross profit66892017548425185
Gross profit:12,42311,63710,6449,9709,5238,5326,075
Operating expenses(4,712)(4,828)(5,125)(4,795)(4,602)(4,666)(3,499)
Other undisclosed operating income (loss)(668)(920)(175)(25)(31)107(60)
Operating income:7,0435,8895,3445,1504,8913,9722,516
Nonoperating income (expense)8311(215)(217)(124)(24)(42)
Investment income, nonoperating12011379  138
Foreign currency transaction gain (loss), before tax(7)(10)6  (12)(15)
Other nonoperating expense(47)(11)(13)(217)(124)(26)(35)
Interest and debt expense(187)(201)(251)(260)(96)(30)(32)
Other undisclosed income from continuing operations before equity method investments, income taxes187201251260962839
Income from continuing operations before equity method investments, income taxes:7,1265,9005,1294,9334,7673,9472,481
Loss from equity method investments(79)   (13)(15)(17)
Income from continuing operations before income taxes:7,0475,9005,1294,9334,7553,9322,463
Income tax expense(1,158)(1,426)(2,459)(1,237)(1,162)(990)(601)
Net income:5,8894,4742,6703,6963,5932,9421,862
Net income (loss) attributable to noncontrolling interest (43)(131)7(46)(7) 
Net income attributable to parent:5,8894,4312,5393,7033,5472,9351,862
Other undisclosed net loss available to common stockholders, basic      (0)
Net income available to common stockholders, diluted:5,8894,4312,5393,7033,5472,9351,862

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income:5,8894,4742,6703,6963,5932,9421,862
Other comprehensive income (loss)10576(2)961653228
Other undisclosed comprehensive income (loss)  3(192)(329)(63) 
Comprehensive income:5,9934,5502,6723,6003,4292,9101,890
Comprehensive income (loss), net of tax, attributable to noncontrolling interest0(43)131(7)467 
Other undisclosed comprehensive income (loss), net of tax, attributable to parent  (262)14(92)(14) 
Comprehensive income, net of tax, attributable to parent:5,9944,5072,5413,6073,3832,9031,890

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: